Vincent Chung, Katherine A. Guthrie, Michael J. Pishvaian, Andrew M. Lowy, Davendra Sohal, Sarah Colby, Kim Anna Reiss, Gazala Khan, Rafael Winograd, Jeffrey A. Meyerhardt, Eileen M. O'Reilly, E. Gabriela Chiorean, Philip Agop Philip. "Randomized phase II trial of olaparib and pembrolizumab vs olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2) mutations: SWOG S2001.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4012